Depo-Provera is a contraceptive injection containing medroxyprogesterone acetate and is given every three months to prevent pregnancy through a hormonal birth control method. A recent study found that women who were given medroxyprogesterone acetate, the active ingredient in Depo-Provera shot, showed a 5.6-fold greater risk of developing meningioma, a type of brain tumor. According to the British Medical Journal (BMJ) authors, nearly 74 million women globally use Depo-Provera and may have serious side effects including blood clots, increased breast cancer risk, and loss of bone density.
The continuous use of Depo-Provera is linked to a risk of intracranial meningioma that requires surgical treatment, according to a population-based study published in March 2024 in BMJ. While the product label mentions warnings for side effects such as irregular vaginal bleeding, weight gain, and abdominal pain, it failed to warn about the risk of bone density loss and pseudotumor cerebri.
Depo-Provera is administered as an intramuscular injection, every three months, is an effective, long-lasting contraception option that does not require daily attention, but there is serious concern about the risk of developing brain tumor.
The manufacturer of Depo-Provera is Pfizer, an American pharmaceutical company with its main headquarters in New York. The pharmaceutical manufacturer earned $7.86 billion in drug sales in 2024. Pfizer was founded in 1849 with the mission of delivering "breakthroughs that change patients’ lives."
In the case of Depo-Provera, Pfizer failed to appropriately warn about the risk of brain tumors, and only a 17% chance of developing headache was mentioned as an adverse neurological reaction.
If you have been diagnosed with meningioma as a result of using the Depo-Provera injection, you may be eligible to file a claim with the manufacturer. We will do a careful evaluation of your medical records to check whether you are legally eligible to file a claim.
To participate in a Depo-Provera lawsuit, you need to fulfill the below criteria:
If you believe that you fulfill all these criteria, we strongly recommend you to contact Atraxia Law, so we can evaluate your claim. We have more than two decades of experience, and if you have a valid Depo-Provera brain tumor claim, we have the necessary knowledge and resources to help you recover your financial compensation.
In April 2024, Pfizer, the manufacturer of Depo-Provera addressed the novel BMJ study through a public statement. Pfizer claimed that they were aware of the potential risk associated with long-term use of progestogens and they are collaborating with regulatory agencies to update the product labels and patient information leaflets with appropriate wordings.
In July 2024, though Pfizer made changes to the prescribing information for Depo-Provera, the warning label for the drug was not modified. Since September 2024, the Depo-Provera meningioma brain tumor lawsuits have drawn significant attention from mass tort lawyers across the nation.